Abstract

Organoids have extensive applications in many fields ranging from modelling human development and disease, personalised medicine, drug screening, etc. Moreover, in the last few years, several studies have evaluated the capacity of organoids as transplantation sources for therapeutic approaches and regenerative medicine. Nevertheless, depending on the origin of the cells and anatomical complications, an organoid transplant may make tissue regeneration difficult. However, some essential aspects of organoids including the morphological alterations and the growth pattern of the matched tumour and their healthy derived organoids have received less attention. Therefore, the current work focused on culturing matched healthy and tumour organoids from the same patient with colorectal cancer (CRC) and assessed their timed growth and structural differences on a daily basis. The healthy organoids underwent proliferation and branching morphogenesis, while the tumour organoids did not follow the same pattern, and the majority of them developed cystic structures instead. However, the number and size of tumour organoids were different from one patient to another. The differential morphological changes of the healthy versus human colonic tumour organoids likely linked to distinct molecular and cellular events during each day. Thus, while their specific structural features provide valuable in vitro models to study various aspects of human intestinal/colon tissue homeostasis and CRC which avoid or replace the use of animals in research, this model may also hold a great promise for the transplantation and regenerative medicine applications.

Highlights

  • Colorectal cancer (CRC) is the third most common malignancy in male and the second in the female worldwide with approximately 1.4 million new cases diagnosed in 2012 [1]

  • The majority of the colorectal cancer (CRC) tumours arise from benign precursors known as the adenoma, which develops into invasive carcinoma [2]

  • Phalloidin functions by binding and stabilising filamentous actin (F-actin) (Supplementary Figure 2), but there was no any benefit to the live-imaging of an organoid with several focus levels forming a bright field stack, and by visualising the intensity variations of this stack using a phase contrast microscope

Read more

Summary

Introduction

Colorectal cancer (CRC) is the third most common malignancy in male and the second in the female worldwide with approximately 1.4 million new cases diagnosed in 2012 [1]. Variations in treatment response and cancer progression patterns between individuals may be due to the heterogeneity of CRC tumours, which defined as interactions of the genetic background of tumour bulk cells with their environment [3]. The differences in genetic and epigenetic properties of each cell and their correlated tumours, construct the level of this heterogeneity as a whole tumour. On the other hand, studying tumour diversity can be facilitated by the development of advanced models that closely resembles the in vivo tumour structure which may provide an alternative platform for the high-throughput studies and analysis. In the last few years, a complex advanced 3-dimensional (3D) culture system known as organoids have been introduced as a model that mimics patients’ in vivo tissue in a variety of pathologic states [4,5,6,7,8,9,10,11,12,13,14,15,16,17]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call